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Ribosome-inactivating proteins (RIPS) from plants inactivate eukaryotic ribosomes, as far as studied by 
rendering their 60 S subunit unable to bind elongation factor 2. These proteins seem widely distributed and 
possibly ubiquitous in plants. They are either type 1, those consisting of a single polypeptide chain, or type 
2 (ricin and related toxins), those consisting of two chains, one of which is a galactose-binding lectin. The 
literature on RIPS from 1982 has been reviewed with respect o (i) the chemical and biological properties 
of RIPS, (ii) their use for the preparation of immunotoxins and (iii) new perspectives. 
Ribosome-inactivating protein 
1. INTRODUCTION 
Ribosome-inactivating proteins from plants, 
reviewed in [l], inactivate eukaryotic ribosomes, as 
far as studied by rendering their 60 S subunit 
unable to bind the elongation factor 2. These pro- 
teins seem to be widely distributed and possibly 
ubiquitous in the plant kingdom. Apart from their 
intrinsic properties, RIPS are attracting con- 
siderable interest for their possible use in the con- 
struction of ‘immunotoxins’, namely conjugates 
with antibodies capable of selectively directing 
them toward specific cell targets (review in 121). 
2. NOMENCLATURE 
A provisional nomenclature of RIPS has been 
proposed [3] pending elucidation ‘of the 
mechanism of action of these proteins which will 
allow the adoption of a more appropriate 
terminology. 
We proposed [I] to designate those RIPS existing 
in nature as single-chain proteins as type 1 and 
Abbrev~utions: IDso, concentration causing 50% inhibi- 
tion; PAP, pokeweed antiviral protein (prepared from 
seeds, PAP-S); RIP(s), ribosome-inactivating protein(s) 
Toxin Immunotoxin 
those consisting of an A (active) chain with RIP 
properties covalently linked to a B (binding) chain 
with lectin properties as type 2; the latter RIPS can 
enter cells more easily and are potent toxins 
(reviewed in [4]). 
The term ‘hemitoxins’ for type 1 RIPS [5] mean- 
ing literally ‘half-toxins’, although elegant, may be 
misleading, giving the impression that type 1 RIPs 
may be half-molecules like the subunits of the tox- 
ins, whereas they are complete, single-chain 
proteins. 
3. GENERAL PROPERTIES 
Up to date lists of RIPS type 1 and 2, with their 
main characteristics, are given in tables 1 and 2, 
respectively. Type 1 RIPS are single-chain proteins 
of Mr -30000 and strongly basic (pZ often 29.5); 
most of them are glycoproteins. Type 2 RIPS con- 
sist of a ribosome-inactivating A chain of M, 
-30000, pZ between 4.8 and 8, linked by a single 
disulphide bond to a heavier B chain which binds 
sugars with the configuration of D-galactose. 
A survey 1311 revealed the presence of proteins 
with the characteristics of type 1 RIPS in most 
plant materials examined, including seeds, roots, 
leaves and latices, thus confirming the wide 
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TabIe 1 
Ribosome-inactivating type 1 proteins 
Source Name Yield M, Sugar Inhibition of Toxicity Refs 
(mg/RJO g) content protein synthesis to 
(To) mice 
Cell-freea Ceilsb (LDso) 
(I&o) (IDso) O&W 
ON OW 
Caryophyllaceae 
Agro~temma githago 
(corn cockle) seeds 
Dianthus caryophyllus 
(carnation) leaves 
Saponaria officinafis 
(carnation) seeds 
Cucurbitaceae 
Luffa cylindrica 
seedse 
Momordica charantia 
(bitter gourd) seedse 
Euphorbiaceae 
Gelonium multiflorum 
seedse 
Hura crepitans 
(sandbox tree) latex 
Gramineae 
Hordeum vulgare 
(barley) seeds 
seeds 
Secale cereak 
(rye) seeds 
Triticum aestivum 
(wheat) seeds 
germ 
Zea mays 
(corn) seeds 
agrostin 2 8.4 
agrostin 5 34.2 
agrostin 6 18.4 
dianthin 30 
dianthin 32 
2 
2 
saporin 5 63 
saporin 6 414 
saporin 9 115 
30600 6.68 0.6 
29500 6.87 0.47 9200 
29600 7.17 0.57 7800 
29500 1.56 0.3 liMOOCd 
31700 2.34 0.12 14~cd 
29500 0.041 
29500 absent 0.037 2300 
29500 absent 0.037 5400 
luffin 51 26000 0.002 
momordin 150-180 31000 1.74 0.06 32000 
gelonin 250-300 30000 2.34 
146 28000 40 
0.4 34000 
0.17 140 
139f 30000 2.13g 
3-4 31000 absent 0.83 
200f 
tritin 
32f 
3 
30000 
30000 
30000 
4.09 
1.87’ 
2.3 
L 
1 
1 
30 
4.0 
1.7 
4.3 
40 
WI 
[71 
[61 
PI 
191 
IlO1 
161 
1111 
1121 
[Ill 
1111 
113, 
141 
35f 23000 2.13g v11 
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Table 1 (continued) 
Source Name Yield MI Sugar Inhibition of Toxicity Refs 
(mg/ 100 g) content protein synthesis to 
Vo) mice 
Cell-freea Cellsb (LDso) 
(IDso) (I&o) (mg/kg) 
tnM) @W 
Liliaceae 
Asparagus officinalis 
(asparagus) seeds 
Phytolaccaceae 
peak 2 24 32500 1.42 0.43 3100 [61 
peak 3 8 32500 1.2 0.37 3100 
peak 5 18 32500 1.32 0.17 3100 
Phytolacca americana 
(pokeweed) leaves 
summer Ieaves 
seeds 
Phytolacca dodecandra 
leaves 
PAP 9.2 29000 absent 0.24 V51 
PAP II 3.6 30000 absent 0.25 1161 
PAP-S 100-180 31000 absent 0.037 33000 2.6 1171 
dodecandrin 3.4 . 29000 0.043 [181 
a Determined on a rabbit reticulocyte iysate, unless stated otherwise 
b Determined on HeLa cells, unless stated otherwise: 18 h incubation 
’ EUE cells 
d F. Stirpe and L. Barbieri (unpublished) 
e Decorticated seeds 
f These figures could not be confirmed in our laboratory 
g Determined on an Ehrlich ascites cell lysate 
distribution of RIPS 132-341. The concentrations 
of RIPS in seeds vary considerably, ranging from 
less than 1 to over 100 mg per 100 g. The higher 
levels were found in the seeds of Caryophyllaceae, 
Cucurbitaceae, Euphorbiaceae and Phytolac- 
caceae, although distribution studies were too 
limited to allow any gener~isation. 
In a few instances more than one form of RIP 
has been purified from the same plant; they differ 
only slightly from each other and can be con- 
sidered as ‘isoforms’ of the same protein. 
In addition to ricin, abrin, modeccin and 
viscumin which have been reviewed previously [4] 
a new toxin, volkensin 1291, has been purified from 
the roots of Adenia vofkensii, a Passifloracea from 
Kenya. This toxin is also present in the seeds of the 
same plant. Volkensin is very similar to the other 
toxins, particularly to modeccin, the toxin of 
another Passifloracea, A. dig~~a~~, ~though being 
more toxic than the latter, especially to rats (LD50 
60 ng/kg body wt) [30]. 
Different RIPS cross-react with specific antisera 
only when they are produced by the same plant or 
by plants belonging to the same family 
f 11,18,30,35-371. Partial amino acid sequences 
showed similarities between RIPS from the same, 
or from different, unrelated plants and even bet- 
ween type 1 RIPS and the A chain of ricin and 
modeccin [37-401, suggesting a common genetic 
origin of these proteins. 
4. EFFECTS OF RIPS ON PROTEIN 
SYNTHESIS 
4.1. Ceil-free systems 
The mechanism of action of RIPS is still unclear. 
3 
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Table 2 
Ribosome-inactivating type 2 proteins (toxins) 
Source Name Yield M Sugar Inhibition of Toxicity Refs 
(mg/ 100 g) content protein synthesis to 
(Q) mice 
Cell-freea Cellsb (J&o) 
(JDso) (IDso) Cug/kg) 
(W (nM) 
Euphorbiaceae 
Ricinus communis 
(castor bean) seeds ricin 
A chain 
B chain 
Leguminosae 
Abrus precatorius 
(jequirity beans) seeds 
Loranthaceae 
V&cum album 
(mistletoe) leaves 
Passifloraceae 
Adenia digitata 
roots 
Adenia volkensii 
(Kilyambiti) roots 
abrin 
A chain 
B chain 
viscumin 
A chain 
B chain 
modeccin 
A chain 
B chain 
volkensin 
A chain 
B chain 
120 
75 
6.8 
20-180 
37.5 
62057 4.5 
30625 2.6 
31432 6.4 
65000 7.4 
30000 absent 
36000 7.4 
60000 9.7 
29000 
32000 
63000 2.66 
28000 
31000 
62000 5.74 
29000 
36000 
84 0.0011’ 
0.1 
88 0.0037’ 
0.5 
43.3 0.008 
3sd 
45 0.0003’ 
2.3 
84 0.0123 
0.37 
2.6 [19-211 
0.56 WI 
2.4 [23-251 
2.3 [26-281 
1.4 P9,301 
a Determined on a rabbit reticulocyte lysate 
b Determined on HeLa cells; 18 h incubation 
’ F. Stirpe and L. Barbieri (unpublished) 
d Reduced toxin 
They inactivate mammalian 80 S ribosomes in a Equally unknown is the nature of the change(s) 
less than equimolar ratio, and thus a possible caused by RIPS in the 60 S subunit of susceptible 
catalytic (enzymic) activity can be postulated, but ribosomes. The extent of ribosomal inactivation 
the nature of this activity is unknown. A pro- depends upon the system used, being greater in a 
teinase activity associated with gelonin has been crude reticulocyte lysate than in a.poly(U)-directed 
described but it seems unrelated to the effect on system containing ribosomes purified from the 
ribosomes [41]. same lysate [6,7]. A ribosome-associated protein 
4 
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and a protein present in the reticulocyte lysate 
seem necessary, under certain conditions, for the 
action of tritin [42] and of PAP [43], respectively. 
Among protozoa, ribosomes from Tetrahymena 
pyriformis [44] and Acanthamoeba castellani [45] 
are insensitive to ricin, although the latter are inac- 
tivated by PAP, with an IDJO (concentration caus- 
ing 50% inhibition) of 0.2-0.4 nM (C.L. Villemez, 
P.L. Carlo and J.D. Irvin, personal 
communication). 
Studies of the effects of RIPS on plant systems 
showed lower and more variable activities on 
ribosomes from plants (especially their own 
species) than on those from animals, ranging from 
zero to an IDso of 10 nM [ 11,46-481. 
Ribosomes from Escherichia coli are unaffected 
by RIPS; amongst archaebacteria, ribosomes from 
Sulfolobus sulfataricus are unaffected, whereas 
those from Thermoplasma cidophilum are inac- 
tivated by dianthin 32 and gelonin, with IDso of 
170 and 100 nM, respectively ([49]; and P. Cam- 
marano, personal communication). 
4.2. Intact cells 
A feature of type 1 RIPS is their relatively low 
toxicity to most intact cells (table 1) with the excep- 
tion of macrophages (ID50 = 10 nM), as compared 
with toxins of the ricin type (table 2), due to the 
absence of a binding B subunit, with consequent 
poor entry into cells. This was confirmed by the 
marked cytotoxic effects which are observed when 
the entry into the cytoplasm was enhanced. This 
was obtained when RIPS were conjugated with 
molecules capable of binding to cell membranes 
(concanavalin A [lo], neoglycoproteins [50], man- 
nose 6-phosphate [51], antibodies, see below), or 
included into structures such as liposomes [52], 
reconstituted Sendai virus envelopes [53] or 
erythrocyte ghosts [54] which could be fused with 
cells (table 3). 
The results of a limited study of the effects of 
RIPS on plant cells in culture were somewhat 
puzzling. Thus the growth of carrot cells was in- 
hibited by PAP, but was stimulated by ricin and, 
to a lesser extent, by gelonin. Furthermore gelonin, 
PAP-S and ricin significantly stimulated the 
growth of rice cells [48]. 
Table 3 
Cytotoxicity of ribosome-inactivating type 1 proteins 
attached to or included in carriers 
Carrier Ribosome- IDso Refs 
inactivating (nM) 
protein 
Concanavalin A 
Glycosylated bovine 
serum albumin 
Mannose 6-phosphate 
Liposomes 
Reconstituted Sendai 
viral envelopes 
Erythrocyte ghosts 
gelonin 20 [lOI 
gelonin 80 WI 
gelonin 500 1511 
gelonin 0.01 [52] 
PAP-S 0.017 [53] 
gelonin 0.06 [54] 
momordin 0.03 
PAP-S 0.06 
saporin 6 0.002 
5. IMMUNOTOXINS 
Various toxins or their A chains have been con- 
jugated to antibodies, mainly monoclonal, to form 
immunotoxins specifically toxic to the target cells 
of the antibody (reviewed in [55]). 
After type 1 RIPS became known, their use was 
proposed as an alternative to the A chains of the 
toxins [lo], the forseeable advantages being their 
easier and safer preparation, their stability, the 
lack of contaminating toxins and the availability of 
a large number of different proteins, with the con- 
sequent possibility of circumventing the immune 
response during long-term in vivo treatment. 
The main characteristics of immunotoxins made 
with type 1 RIPS are summarized in table 4. 
Hopefully immunotoxins will be useful in the 
chemotherapy of cancer and parasitic diseases; 
they have already been used to remove T- 
lymphocytes from bone marrow heterografts, thus 
preventing the graft-versus-host reaction [63]. 
An unexpected and disturbing observation was 
that immunotoxins made with saporin 6 and an 
anti-Thyl.1 antibody or its F(ab’)2 fragment were 
4-8-fold more toxic to mice than free saporin 6 
[62]. This higher toxicity is probably due to the 
longer persistence of the immunotoxins in the 
bloodstream, where they remain for some hours, 
whereas free saporin is quickly excreted through 
the kidney (unpublished). 
5 
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Table 4 
Immunotoxins made with ribosome-inactivating type 1 proteins 
Ribosome-inactivating 
protein 
Gelonin 
PAP 
Saporin 6 
Antibody Target cells IDSO References 
against (nM) 
Thyl. 1 T-lymphocytes 0.001-0.4 [561 
AKR lymphomas 1 OO- 1300 
T-lymphoblasts 100 
Thyl.2 EL4 3 [571 
Burkitt’s 
associated . 
glycolipid Ramos (EL cells) 0.8 l581 
L-1210 L-1210 3 1591 
human B cells B-ALL 400 151 
Thyl. 1 AKR SL3 3-30 [60,611 
transferrin human breast 
receptor tumour (MCF-7) 0.7 WI 
Thyl. 1 T-lymphocytes 0.1 WI 
AKR lymphomas 0.003-0.03 
January 1986 
6. EFFECTS OF RIPS ON THE IMMUNE 
SYSTEM 
Macrophages are more sensitive to RIPS than 
other cells [64]. In view of the role of macrophages 
in the immune system, the effects of PAP and 
momordin [64] and subsequently of gelonin [65] 
on various forms of the immune response were 
studied. These RIPS all exerted a strong inhibitory 
effect on the production of antib~y-secreting cells 
in response to the administration of a T-dependent 
antigen, with no (PAP and momordin) or less ef- 
fect (gelonin) on the antibody formation against a 
T-independent antigen. Other effects were in- 
vestigated separately: PAP-S and momordin 
significantly delayed the rejection of skin 
allografts in mice, gelonin depressed the response 
to Listeria monocytogenes and allowed the growth 
of L-1210 leukaemic ells in incompatible mice. All 
these effects occurred only if the RIPS were ad- 
ministered to mice some time before, and not 
together with, or after, the antigens. This indicates 
that the RIPS must act at a very early stage of the 
immunity-forming process, affecting a step which 
is already accomplished when RIPS given together 
with antigen hit their target(s). This would be con- 
sistent with the notion of an immunosuppressive 
effect mediated through the action of RIPS on 
macrophages. An apparently enhanced cytotoxic 
6 
activity of macrophages from mice given PAP-S or 
momordin [64], which was however not observed 
in animals receiving gelonin 1651, could possibly be 
due to the toxic action of substances released in 
vitro by damaged or dying macrophages. 
7. PERSPECTIVES 
Two main unanswered questions on the 
biological role of RIPS emerge from the existing 
literature, namely, (i) the nature of their 
mechanism of action and (ii) the role of these pro- 
teins in the physiology of the plants. Obviously, 
the two questions are related, but unfortunately 
the numerous efforts of several laboratories have 
given only vague clues concerning the mode of ac- 
tion of RIPS. Our views on the matter can be sum- 
marized as follows. 
(i) The fact that no cofactors, donors or accep- 
tors are required for the inactivation of ribosomes 
by RIPS seems to exclude any type of transfer reac- 
tion, such as alkylation, phosphorylation, etc. 
(ii) Since no detectable modification of the 
ribosomal protein or RNA have been reported, the 
change(s) caused by RIPS in ribosomes are likely to 
be small. However, the complete arrest of protein 
synthesis induced by RIPS suggests that the 
change(s) must occur in a functionally important 
region in the 60 S ribosomal subunit, probably at, 
Volume 195, number 1,2 FEBS LETTERS January 1986 
or near to, the binding site for elongation factor 2, 
(iii) There must be differences in the specificity 
or some other characteristics of RIPS, as indicated 
by the different effect of any given RIP on 
ribosomes from different plants [48], and by the 
inactivation of AC. ~~sf~~~a~ii by PAP but not by 
ricin ([45] and see above). 
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